The abstract is read at the publisher; the summary is JClub's.
Computational mining has identified over 5000 antimicrobial peptide (AMP) and AMP-like domain genes, but validating their activity and mode of action remains the key bottleneck.
- Why it matters: Multidrug-resistant bacteria and parasitic nematodes require new antimicrobial strategies, and the nematode–gut microbiota “holobiont” suggests AMPs may be especially relevant.
- What they did: The work uses computational mining to catalog AMP genes, then proposes combining machine learning with advanced in vitro and ex vivo models to predict mode of action, spectrum, and efficacy.
- The result: Predicted AMPs would be tested in organoids to validate activity while addressing limitations of animal models, enabling more reliable selection of candidates.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.